InvestorsHub Logo
Followers 84
Posts 12534
Boards Moderated 0
Alias Born 07/25/2008

Re: zzaatt post# 73095

Monday, 05/23/2016 5:59:12 PM

Monday, May 23, 2016 5:59:12 PM

Post# of 80490
There was absolutely no overreaction by the FDA. Ariad's Ponatinib had an unacceptable level of toxicity at 45 mg, period. It is in the trial data.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.